Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-Species Multi-Modal Neuroimaging to Investigate GABA Physiology in Fragile X Syndrome

NCT04308954 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04308954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04308954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-Species Multi-Modal Neuroimaging to Investigate GABA Physiology in Fragile X Syndrome
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Terminated
Start date
November 1, 2016
Completion date
December 6, 2018
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fragile x syndrome (fxs), idiopathic intellectual developmental disorder (idd)